uniQure (QURE) Share-based Compensation (2016 - 2026)
uniQure's (QURE) quarterly Share-based Compensation came in at $5.1 million in Q1 2026, up 15.42% year-on-year from $4.4 million in Q1 2025, and up 9.16% quarter-over-quarter from $4.7 million in Q4 2025.
uniQure (QURE) Share-based Compensation (2016 - 2026) Analysis & Trends
uniQure's Share-based Compensation history runs 11 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 15.42% year-over-year to $5.1 million in Q1 2026; TTM through Mar 2026 was $18.9 million, a 106.22% increase from a year earlier, with the FY2025 full-year figure at $32.3 million, up 45.03% from the prior year.
- Share-based Compensation improved to $5.1 million in Q1 2026 per QURE's latest filing, from $4.7 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $13.6 million in Q3 2025 and bottomed at $2000.0 in Q3 2024.
- The 5-year median for Share-based Compensation is $4.7 million (2024), against an average of $5.1 million.
- Across the five-year window, Share-based Compensation plunged 99.91% in 2024 and surged 680950.0% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at $11.9 million in 2022, then plunged by 40.9% to $7.0 million in 2023, then tumbled by 32.55% to $4.7 million in 2024, then dropped by 1.81% to $4.7 million in 2025, then rose by 9.16% to $5.1 million in 2026.
- Per Business Quant, the three latest QURE Share-based Compensation figures stand at $5.1 million (Q1 2026), $4.7 million (Q4 2025), and $13.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9.26 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.18 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 87.30 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.09 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Sep 30, 2025 | 13.62 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.21 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 7.19 Mn |
| Mar 31, 2024 | 7.19 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Dec 31, 2023 | 7.04 Mn |